BTNA
CMD

Bremer Trust National Association’s Cantel Medical Corporation CMD Stock Holding History

Bremer Trust National Association’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$25K Buy
+342
New +$28.2K 0.01% 547

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bremer Trust National Association's CMD Position: Q4 2018 in Review

Bremer Trust National Association opened a new position in Cantel Medical Corporation (CMD) in Q4 2018: 342 shares worth $25K. The stake represents 0.01% of the portfolio and ranks #547 among its holdings.

253 funds tracked by Wall St. Rank hold CMD as of Q4 2018.

  • Bremer Trust National Association held 342 shares of Cantel Medical Corporation worth $25K as of Q4 2018.
  • Cantel Medical Corporation was a new Bremer Trust National Association position in Q4 2018.
  • Cantel Medical Corporation made up 0.01% of Bremer Trust National Association's portfolio in Q4 2018, its #547 holding.
  • 253 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.